News
The approval makes Wegovy the only GLP-1 therapy cleared to treat adults with metabolic dysfunction-associated ...
The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New ...
The U.S. health regulator has allowed a study of Rocket Pharmaceuticals' gene therapy to resume, less than three months after ...
Rocket Pharmaceuticals' shares rallied ahead of the opening bell after the Food and Drug Administration lifted its clinical hold on the biotechnology company's Phase 2 trial of its RP-A501 treatment ...
The FDA has approved Sisnos’s continuous glucose monitoring (CGM) system for consumer use beyond diabetes management, ...
The hits just keep on coming for Regeneron’s Eylea franchise. | The FDA has extended its target action dates for two ...
In light of this, dermatologist Adam Friedman of the George Washington University has shared with Newsweek how you can choose ...
The regulatory body determined that PTC Therapeutics’ New Drug Application for vatiquinone did not provide sufficient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results